Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

Treating Newly-Diagnosed Crohn's Patients With Advanced Therapy Leads to Dramatic Improvements in Outcomes Feb. 22, 2024 — A large-scale clinical trial of treatment strategies for Crohn's ...

The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...

The resulting paper, "Early tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: Post-hoc analysis of the RISK study," appears in Gut.

Vedolizumab treatment within 4 weeks of ileocolonic resection outperformed placebo in preventing postoperative endoscopic recurrence of Crohn’s disease in patients with at least one risk factor ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.

A study may explain why some patients with Crohn's disease continue to experience symptoms, even in the absence of inflammation. A study from University of Michigan researchers may provide an ...

A recent study reveals that anti-TNF drugs significantly reduce the risk of anal fistulas in children with Crohn's disease.

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

The persistence of symptoms with quiescent Crohn's disease remains a challenge for overall treatment of the condition. While many patients try to reach remission for inflammation, the remaining ...